A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus

Journal of the American Academy of Dermatology

Volumn 42, Issue 3, 2000, Pages 520-522

  Suga, Yasushi ^a   Tsuboi, Ryoji ^a   Hashimoto, Yukiko ^a   Yoshiike, Takashi ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; ICHTHYOSIS; MALE; PRIORITY JOURNAL; SYMPTOM;

EID: 0033927093     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90234-2     Document Type: Article

References (13)

1. Comel M. Ichthyosis linearis circumflexa. Dermatologica 1949;98:133-6.
2. Wilkinson RD, Curtis GH, Hawk WA. Netherton's disease - trichorrexis invaginata (bamboo hair) congenital erythroderma and atopic diathesis: a histopathologic study. Arch Dermatol 1964;89:46-54.
3. Yoshiike T, Manabe M, Negi M, Ogawa H. Ichthyosis linearis circumflexa: morphological and biochemical studies. Br J Dermatol 1985;112:277-83.
4. Netherton EW. A unique case of trichorrexis nodosa: 'bamboo hairs.' Arch Dermatol 1958;78:483-7.
5. Aoyama H, Tabata N, Tanaka M, et al. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br J Dermatol 1995;133:494-6.
6. Happle R, van de Kerkhof PC, Traupe H. Retinoids in disorders of keratinization: their use in adults. Dermatologica 1987; 175(Suppl 1):107-24.
7. Hausser I, Anton-Lamprecht I, Hartschuh W, et al. Netherton's syndrome: ultrastructure of the active lesion under retinoid therapy. Arch Dermatol Res 1989;281:165-72.
8. Braun RP, Ramelet AA. Failure of cyclosporine in Netherton's Syndrome. Dermatology 1997;195:75.
9. Manabe M, Yoshiike T, Negi M, et al. Successful therapy of ichthyosis linearis circumflexa with PUVA. J Am Acad Dermatol 1983;8:905-7.
10. Ockenfels HM, Nussbaum G, Schneck B, et al. The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytes. Skin Pharmacol 1996;9:281-8.
11. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-42.
12. Karashima T, Hachisuka H, Sasai Y. FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle. J Dermatol Sci 1996;12:246-54.
13. Prignano F, Domenici-Lombardo L, Gerlini G, et al. Cyclosporin-A affects the organization of cytoskeleton of normal human keratinocytes in culture. Histol Histopathol 1996;11:889-94.